Hans E. Bishop

2014

In 2014, Hans E. Bishop earned a total compensation of $7.3M as President, Chief Executive Officer and Director at Juno Therapeutics, a 2,867% increase compared to previous year.

Compensation breakdown

Bonus$246,000
Non-Equity Incentive Plan$204,000
Option Awards$4,286,446
Salary$425,000
Stock Awards$2,156,250
Total$7,317,696

Bishop received $4.3M in option awards, accounting for 59% of the total pay in 2014.

Bishop also received $246K in bonus, $204K in non-equity incentive plan, $425K in salary and $2.2M in stock awards.

Rankings

In 2014, Hans E. Bishop's compensation ranked 896th out of 13,032 executives tracked by ExecPay. In other words, Bishop earned more than 93.1% of executives.

ClassificationRankingPercentile
All
896
out of 13,032
93rd
Division
Manufacturing
318
out of 4,965
94th
Major group
Chemicals And Allied Products
105
out of 1,690
94th
Industry group
Drugs
81
out of 1,369
94th
Industry
Biological Products, Except Diagnostic Substances
7
out of 241
97th
Source: SEC filing on April 21, 2017.

Bishop's colleagues

We found two more compensation records of executives who worked with Hans E. Bishop at Juno Therapeutics in 2014.

2014

Steven Harr

Juno Therapeutics

Chief Financial Officer

2014

Mark Frohlich

Juno Therapeutics

Executive Vice President, Portfolio Strategy

In-depth

You may also like